MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 119, Issue 1, 2015, Pages 74-82

  Jessri, M ^a,b   Dalley, A J ^a   Farah, C S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; DNA LIGASE; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; MUTLALPHA PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; PROTEIN MSH2; PROTEIN MUTS; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOLESCENT; ADULT; AGED; BIOPSY; CANCER GRADING; CARCINOMA IN SITU; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MISMATCH REPAIR; MOUTH TUMOR; PATHOLOGY; PRECANCER; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; BIOPSY; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTS DNA MISMATCH-BINDING PROTEIN; MUTS HOMOLOG 2 PROTEIN; NEOPLASM GRADING; NUCLEAR PROTEINS; PRECANCEROUS CONDITIONS; SEX FACTORS;

EID: 84916237128     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2014.06.017     Document Type: Article

References (32)

1. B.W. Neville, and T.A. Day Oral cancer and precancerous lesions Ca-a Cancer J Clinicians 52 2002 195 215
2. J. Califano, P. vanderRiet, and W. Westra Genetic progression model for head and neck cancer: implications for field cancerization Cancer Res 56 1996 2488 2492
3. M.C. Haya-Fernandez, J.V. Bagan, J. Murillo-Cortes, R. Poveda-Roda, and C. Calabuig The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma Oral Dis 10 2004 346 348
4. S.S. Napier, and P.M. Speight Natural history of potentially malignant oral lesions and conditions: an overview of the literature J Oral Pathol Med 37 2008 1 10
5. A.J. Dalley, L.P. Pitty, A.G. Major, A.A. Abdulmajeed, and C.S. Farah Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma Cancer Med 3 2014 273 283
6. N. Tanic, N. Tanic, J. Milasin, M. Vukadinovic, and B. Dimitrijevic Genomic instability and tumor-specific DNA alterations in oral leukoplakias Eur J Oral Sci 117 2009 231 237
7. S. Jones, T.L. Wang, and R.J. Kurman Low-grade serous carcinomas of the ovary contain very few point mutations J Pathol 226 2012 413 420
8. M.A. Ramírez-Ramírez, S. Sobrino-Cossío, and J.G. de la Mora-Levy Loss of expression of DNA mismatch repair proteins in aberrant crypt foci identified in vivo by magnifying colonoscopy in patients with hereditary nonpolyposic and sporadic colon rectal cancer J Gastrointest Cancer 43 2012 209 214
9. N. Buerki, L. Gautier, and M. Kovac Evidence for breast cancer as an integral part of lynch syndrome Genes Chromosomes Cancer 51 2012 83 91
10. T.A. Kunkel, and D.A. Erie DNA mismatch repair Annu Rev Biochem 74 2005 681 710
11. P. Hsieh, and K. Yamane DNA mismatch repair: molecular mechanism, cancer, and ageing Mech Ageing Dev 129 2008 391 407
12. H.T. Lynch, and A. De la Chapelle Hereditary colorectal cancer N Engl J Med 348 2003 919 932
13. E. Barrow, E. Jagger, and J. Brierley Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome Histopathology 56 2010 331 344
14. I. González-Ramírez, V. Ramírez-Amador, and M.E. Irigoyen-Camacho HMLH1 promoter methylation is an early event in oral cancer Oral Oncol 47 2011 22 26
15. R. Czerninski, S. Krichevsky, Y. Ashhab, D. Gazit, V. Patel, and D. Ben-Yehuda Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma Oral Dis 15 2009 206 213
16. A.M. Fernandes, M.L. Ramos-Jorge, S.V. Cardoso, A.M. Loyola, R.A. Mesquita, and M.C.F. Aguiar Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histologic grades of malignancy J Oral Pathol Med 37 2008 543 548
17. P.C. Caldeira, M.H.N.G. Abreu, A.C. Batista, and M.A.V. Do Carmo hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia J Oral Pathol Med 40 2011 153 159
18. P.C. Caldeira, M.C.F. Aguiar, R.A. Mesquita, and M.A.V. do Carmo Oral leukoplakias with different degrees of dysplasia: comparative study of hMLH1, p53, and AgNOR J Oral Pathol Med 40 2011 305 311
19. H.M. Tawfik, N.M.R.A. El-Maqsoud, B.H.A.A. Hak, and Y.M. El-Sherbiny Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene Am J Otolaryngol Head Neck Med Surg 32 2011 528 536
20. J. Nunn, S. Nagini, and J.M. Risk Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck Oral Oncol 39 2003 115 129
21. L. Barnes, J.W. Eveson, P. Reichart, and D. Sidransky World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours 9th ed. 2005 IARC Press Lyon, France
22. A.J. Dalley, A.A. Abdulmajeed, Z. Upton, and C.S. Farah Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy J Oral Pathol Med 42 2013 37 46
23. A.M. Fernandes, V.R.D.C. De Souza, and C.R.A. Springer Tobacco and inflammation effects in immunoexpression of hMSH2 and hMLH1 in epithelium of oral mucosa Anticancer Res 27 2007 2433 2437
24. W. Müller, L.J. Burgart, and R. Krause-Paulus The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study Familial Cancer 1 2001 87 92
25. P. Modrich, and R. Lahue Mismatch repair in replication fidelity, genetic recombination, and cancer biology Annu Rev Biochem 65 1996 101 133
26. C. D'Arcy, Y.H. Wen, Z.K. Stadler, E. Brogi, and J. Shia Synchronous breast cancers with different morphologic and molecular phenotypes occurring in lynch syndrome: what does the heterogeneity imply? Am J Surg Pathol 35 2011 1743 1748
27. Y. Karamurzin, Z. Zeng, and Z.K. Stadler Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature Hum Pathol 43 2012 1677 1687
28. L.R. Souza, T. Fonseca-Silva, and C.S. Pereira Immunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma Histopathology 58 2011 352 360
29. K. Liu, H. Huang, P. Mukunyadzi, J.Y. Suen, E. Hanna, and C.Y. Fan Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma Otolaryngol Head Neck Surg 126 2002 548 553
30. J. Shia, N.A. Ellis, and D.S. Klimstra The utility of immunohistochemical detection of DNA mismatch repair gene proteins Virchows Arch 445 2004 431 441
31. X. Wang, M. Fan, and X. Chen Intratumor genomic heterogeneity correlates with histologic grade of advanced oral squamous cell carcinoma Oral Oncol 42 2006 740 744
32. S.S. Wahlberg, J. Schmeits, and G. Thomas Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families Cancer Res 62 2002 3485 3492